PAPPA and cardiomyopathy: Although Pappa deletion did not extend the lifespan of PolgAD257A mice, it did attenuate a wide range of age-related phenotypes, including splenomegaly, anemia, chronic inflammation, skeletal muscle decline, and cardiomyopathy.